H2-O Inhibits Presentation of Bacterial Superantigens, but Not

C D4
ϩ T lymphocytes are activated by antigenic peptides presented by MHC class II molecules of APC. MHC class II-associated accessory molecules play an essential role in guiding MHC class II molecules in their intracellular trafficking patterns and in shaping the class II peptide repertoire (1) . In classic exogenous Ag presentation, invariant chain (Ii) 3 binds to newly synthesized class II molecules, preventing the binding of peptides in the endoplasmic reticulum (ER) and directing class II/Ii complexes to endocytic compartments and/or MHC class II compartments (MIICs). In the MIICs, Ii is progressively degraded to MHC class II-associated Ii peptide, which is subsequently displaced by higher affinity peptide with the help of H2-DM (HLA-DM in humans). A third accessory molecule, H2-O (HLA-DO in humans), is also implicated in MHC class II-restricted exogenous Ag presentation. In the absence of H2-DM, H2-O is retained in the ER (2) . However, when H2-DM is coexpressed, then H2-O is transported from the ER to the MIIC, where in combination with H2-DM it alters the repertoire of peptides bound to MHC class II molecules (3) (4) (5) (6) (7) . Unlike Ii and H2-DM, which are ubiquitously expressed in all professional APC, H2-O is mainly expressed in B lymphocytes and medullary thymic epithelial cells (mTEC) (8, 9) . Because B cells present superantigens (SAgs) as well as exogenous Ags, and mTEC present endogenous self Ags during negative selection of T cells in the thymus (10), we have hypothesized that H2-O might play a role in MHC class II-restricted SAgs and self Ag presentation.
We have tested this hypothesis by generating H2-O-transfected cells and using the transfectants as APC for SAgs and self Ags. Because earlier reports showed that H2-O also interacts with Ii (2, 8), we have assessed the effects of H2-O in the presence or absence of Ii. Our results demonstrate that H2-O inhibits SAg presentation, but does not affect endogenous self Ag presentation. We have also examined H2-O effects on exogenous Ag presentation and find that H2-O inhibits presentation of exogenous peptides associated with both newly synthesized and recycling MHC class II molecules. In no case does Ii expression alter the functions of H2-O, suggesting that H2-O is a potent inhibitor of SAg and exogenous Ag presentation via an Ii-independent mechanism.
Materials and Methods
Cell lines and transfections
SaI is a MHC class II-negative A/J-derived spindle cell sarcoma (11) . SaI/A k , SaI/A k /DM, SaI/A k /Ii, SaI/CIITA (MHC class II transcriptional activator), and their hen egg lysozyme (HEL)-transfected SaI cells (SaI/ A k /DM/HEL and SaI/A k /Ii/HEL) were previously described. In these transfectants, HEL is tagged with a (KDEL) signal which causes HEL to be retained in the ER (12, 13) . H2-O transfectants were generated as described (13) using the pCMU/Oa and pCMU/Ob plasmids encoding the H2-O␣-and H2-O␤-chains, respectively. Transfectant nomenclature uses "DM" and "DO" for H2-DM and H2-O, respectively. Cells expressing H2-O were selected in 1.5 g/ml puromycin (BD Biosciences, San Jose, CA) for SaI/ A k /DM/DO and SaI/A k /DM/HEL/DO cells, or 400 g/ml hygromycin (Calbiochem, La Jolla, CA) for SaI/CIITA/DO cells, tested by flow cytometry, and then cloned by limiting dilution.
Flow cytometry
Tumor cells were stained by indirect immunofluorescence either internally or externally, and analyzed on an Epics XL flow cytometer, as previously described (13) .
RT-PCR
Total RNA was extracted using a RNeasy Minikit (Qiagen, Valencia, CA), according to the manufacturer's directions. A total of 100 ng RNA was amplified using a one-step RT-PCR kit (Qiagen) and the following conditions: 50°C ϫ 30 min and 95°C ϫ 15 min, followed by 30 cycles of 95°C ϫ 30 s, 60°C ϫ 30 s, and 72°C ϫ 30 s. H2-Oa 5Ј primer, CCTTCTACCA ATCTTACGACGC, and 3Ј primer, GTGTGCCTGTGATCATGAGCAC; H2-Ob 5Ј primer, TGGTCCTAACCGTAATGAGCTTCCTG, and 3Ј primer, GTTCCACCAAGATGTCCAGATGAGCT.
Cell surface biotinylation
Log-phase cells (Ͼ95% viability) were washed twice with cold PBS containing 0.1 mM CaCl 2 and 1 mM MgCl 2 , and resuspended at 10 7 /ml in 0.5 mg/ml sulfo-N-hydroxy succinimide-long chain-biotin (Pierce, Rockford, IL) for 30 min at 4°C with gentle shaking. The reaction was stopped by addition of glycine to a final concentration of 10 mM. Biotinylated cells were washed twice with excess PBS and subjected to immunoprecipitation.
Immunoprecipitation
All procedures were conducted at 4°C. A total of 3 ϫ 10 7 tumor cells/ml or 3 ϫ 10 8 splenocytes/ml was incubated in lysis buffer (20 mM Tris, pH 8, 150 mM NaCl, 5 mM EDTA, and 1% Nonidet P-40) containing protease-inhibitor cocktails (Roche, Indianapolis, IN) for 40 min, and lysates were microcentrifuged for 30 min to remove nuclei and cellular debris. Resulting supernatants were divided into 100-l aliquots and were precleared once with 0.2 l rabbit serum and twice with 50 l 10% protein G-Sepharose (Amersham Pharmacia Biotech, Piscataway, NJ). Precleared supernatants were incubated with 0.2 l K535 or 3 g 9E10 for 1 h, followed by addition of 200 l 10% protein G-Sepharose for another 1 h. The resulting immunoprecipitates were pelleted by microcentrifugation and washed four times with wash buffer (50 mM Tris, pH 8, 150 mM NaCl, and 0.1% Nonidet P-40).
Endoglycosidase H (endo H) assay
Immunoprecipitated beads were resuspended in 40 l endo H buffer (20 mM Na 2 PO 4 , pH 6.5, 0.1% SDS, and 0.02% NaN 3 ) and boiled for 5 min. After microcentrifugation at room temperature, the supernatants were divided into two aliquots. Recombinant endo H (2 mu; Roche) was added to one aliquot, and both aliquots were incubated overnight at 37°C and then boiled for 5 min to inactivate endo H before analysis by Western blot.
Western blot
Western blot analyses were performed as described (18) using 12% SDS-PAGE. For c-myc or H2-O␤ analysis, incubation with 9E10 (1:500) or K535 (1:3000) was followed by sheep anti-mouse or donkey anti-rabbit HRP (1:10,000; Amersham), respectively. In surface biotinylation assays, biotinylated proteins were visualized with streptavidin-HRP (1:20,000; Pierce). Bands were quantified by densitometry using National Institutes of Health Scion Image software (http://www.scioncorp.com).
SAg-binding analysis
APC at 5 ϫ 10 5 /ml in PBS/2% FCS were incubated with 10 g/ml biotinylated SEB (Toxin Technology, Sarasota, FL) for 45 min at 37°C and washed four times with PBS before incubation with 30 l 2.5 g/ml streptavidin-PE (BD Biosciences) for 20 min at 4°C. Following labeling, the cells were washed at 4°C four times with PBS, and SAg binding was quantified by flow cytometry. Fluorescence intensity ϭ (anti-log of mean channel fluorescence with biotin-SEB ϩ streptavidin-PE) Ϫ (anti-log of mean channel fluorescence with streptavidin-PE).
Ag presentation assays
SAg-reactive and Ag-specific CD4 ϩ T hybridoma cells used in this study are shown in Table I . Exogenous and endogenous Ag presentation assays were performed as described (13) . For SAg presentation assays, 5 ϫ 10 4 APC were incubated with 5 ϫ 10 4 T hybridoma cells plus SAg for 18 -20 h at 37°C. For exogenous Ag presentation assays with chloroquine or BFA, 1.5 ϫ 10 5 SaI/A k /DM or SaI/CIITA cells were incubated at 37°C with chloroquine for 30 min or BFA for 15 min, followed by addition of native HEL, RNase, or HEL 46 -61 peptide for an additional 4 -5 h. Chloroquine or BFA was present during the incubation with Ag. To ensure adequate T cell responses, different concentrations of Ag were used for different APC and hybridoma cells. SaI/A k /DM and SaI/CIITA cells were pulsed with HEL at 1 mg/ml for 3A9 and 3B11.1, RNase at 1 mg/ml for TS12, or HEL 46 -61 peptides at 100 g/ml for 3A9. SaI/A k /DM cells were pulsed with HEL at 8 mg/ml for 2B6.3, 2D4.1, and 1B9. SaI/CIITA cells were pulsed with HEL at 20 mg/ml for 2B6.3. SaI/CIITA/DO.G1 cells were pulsed with HEL at 2 mg/ml for 2B6.3, 3A9, and 3B11.1, or with RNase at 10 mg/ml for TS12. SaI/A k /DM/DO.7 cells were pulsed with HEL at 10 mg/ml for 2B6.3, 2D4.1, and 1B9, with HEL at 2 mg/ml for 3B11.1 and 3A9, or with RNase at 10 mg/ml for TS12. Following incubation with Ag, the APC were fixed with 0.05% glutaraldehyde for 30 s on ice, quenched in 200 mM glycine, and washed twice with PBS and once with culture medium. A total of 5 ϫ 10 4 Ag-loaded, fixed APC was then incubated with 7 ϫ 10 4 T hybridoma cells for 18 -20 h at 37°C. Ag-specific and SAg-mediated T cell activation was measured by quantifying the amount of IL-2 in the assay supernatants using an IL-2 ELISA (Pierce), as previously described (12) . Values are the average of triplicate cultures Ϯ SD. In experiments using chloroquine or BFA, percentage of response ϭ 100% ϫ ((IL-2 with drug )/ (IL-2 without drug )).
Mice and tumor challenges
C57BL/6 H2-Oa ϩ (H2-O␣ ϩ ␤ ϩ ) and H2-Oa Ϫ (H2-O␣ Ϫ ␤ ϩ ) mice were previously described (5) . A/J mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were housed and bred in the Biology Department animal facility. Six-to eight-week-old male and female mice were used. Tumor challenges were performed as previously described (12) . All animal procedures have been approved by the University of Maryland Baltimore County Institutional Animal Care and Use Committee.
Results
Characterization of H2-O-expressing SaI cells
To study the functions of H2-O in the absence or presence of Ii, SaI/A k /DM and SaI/CIITA cells were transfected with plasmids encoding H2-O␣-and H2-O␤-chains, respectively (SaI/A k / DM/DO and SaI/CIITA/DO cells). Fig. 1 , A and B, shows the flow cytometry profiles of three SaI/A k /DM/DO clones (clones 4, 5, and 7) and two SaI/CIITA/DO clones (clones A10 and G1), respectively, stained for surface MHC class II (I-A k ) and internal H2-DM, H2-O, and/or Ii. In CIITA-transduced cells, MHC class II, Ii, and H2-DM, but not H2-O, are coordinately up-regulated (26). To ascertain that H2-O␣␤ complexes leave the ER and medial Golgi, endo H assays were performed on H2-O immunoprecipitates. Treatment with endo H reduces the molecular mass of H2-O by removing N-linked high mannose, but not complex-type oligosaccharides. Protein glycosylation with high mannose or complextype oligosaccharides occurs in the ER/medial Golgi or the trans Golgi/trans Golgi network, respectively. Therefore, when proteins leave the ER and medial Golgi, they are endo H resistant. As shown in Fig. 1D, ϳ90 (27) . The role of H2-O in modulating MHC class II SDS stability is controversial (3-7). To determine the effect of H2-O on I-A k molecules in the SaI transfectants, boiled and nonboiled cell extracts were Western blotted and probed for I-A␤ k . As shown in Fig. 1E , the percentage of SDS-stable MHC class II dimers in H2-O ϩ and H2-O Ϫ transfectants is similar (41-53% in SaI/A k and 75-80% in SaI/CIITA transfectants, respectively). Therefore, H2-O does not significantly alter SDS stability of I-A k molecules.
H2-O inhibits presentation of bacterial SAg to T cells
SEB activates murine T cells by binding to the V␤7, V␤8, or V␤17 region of the TCR and ␣-chain of the MHC class II of the APC (28). To determine whether H2-O affects SEB presentation, SaI dimers; ␤, free I-A␤ k chain; Aggr., aggregates; C% ϭ 100% ϫ ((density of C)/(density of (C ϩ ␤ ϩ Aggr.))). These data are representative of at least two independent experiments. cells with or without H2-O were incubated with two V␤8 ϩ T hybridoma cells (Table I ) that release IL-2 in response to SEB presentation. As shown in Fig. 2A To determine whether H2-O has the same effect on other SAgs, the same transfectants were tested as APC for activation of the SEA-reactive V␤1 T hybridoma cell A2.A2. As shown in Fig. 3 , presentation of SEA to A2.A2 T cells is uniformly inhibited by H2-O. Therefore, presentation of SAgs is markedly reduced if the APC expresses H2-O, regardless of expression of Ii.
H2-O prevents binding of SAgs to MHC class II molecules
H2-O may inhibit SAg presentation by reducing SAg binding to surface class II molecules. To test this hypothesis, SEB binding to H2-O
ϩ and H2-O Ϫ transfectants was quantified by flow cytometry using biotinylated SEB. As shown in Fig. 4 
H2-O does not alter tumorigenicity nor affect presentation of endogenous self Ags
MHC class II molecules also present endogenous self Ags (29) . We have exploited this phenomenon and used SaI/A k sarcoma a Syngeneic A/J mice were inoculated i.p. with 10 6 tumor cells and followed for 2 months for tumor development. Tumor incidence is the number of mice with palpable tumor/total number of mice injected. cells as cancer vaccines (30) . The vaccines were originally designed to directly present endogenous tumor Ags to host CD4 ϩ T cells. In vitro Ag presentation (12, 13) I-A k -restricted T hybridoma cells (Table I) . Previous studies demonstrated that the HEL proteins in these transfectants are retained in the ER and are not secreted or present at the cell surface (18) . (12, 18) . In all cases, the SaI/A k /DM/HEL/DO clones are comparable with SaI/ A k /DM/HEL cells in presenting three HEL epitopes, confirming that H2-O expression does not alter presentation of endogenous self Ags.
H2-O affects presentation of exogenous Ags by newly synthesized and recycling MHC class II molecules
The effect of H2-O on presentation of exogenous Ags has been previously tested, and the results are controversial. In some studies, H2-O expression inhibits exogenous Ag presentation (5, 7), while in other studies H2-O enhances presentation (5, 6) . Using five HEL-specific and one RNase-specific, I-A k -restricted T hybridomas (Table I) , we have tested H2-O transfectants as APC for exogenous HEL and RNase, respectively. As shown in Fig. 6 , three SaI/A k /DM/DO clones (Fig. 6A) and two SaI/CIITA/DO clones (Fig. 6B) are inhibited for presentation of all tested HEL and RNase epitopes relative to parental SaI/A k /DM and SaI/CIITA cells. The inhibition is not due to dysfunctional MHC class II molecules because H2-O ϩ clones efficiently present exogenously pulsed peptides (data not shown). Therefore, H2-O consistently inhibits presentation of exogenous Ags by both Ii ϩ and Ii Ϫ APC. Previous studies have established that both newly synthesized and recycling MHC class II molecules present exogenous Ags (32) (33) (34) . To determine whether H2-O differentially affects presentation of these two pools of MHC class II molecules, we have treated APC with drugs that selectively inhibit Ag processing and presentation. Chloroquine, a lysosomotropic amine, interferes with the acidification of MIICs, which in turn blocks presentation of exogenous Ags in these compartments (35) . As shown in Fig. 7B , presentation of all epitopes by SaI/CIITA and SaI/A k /DM, except HEL [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] , is inhibited by chloroquine, suggesting endosomal trafficking is required for most epitopes. BFA prevents transport of newly synthesized proteins from the ER, and hence blocks trafficking of newly synthesized MHC class II molecules, while having minimal effect on recycling class II (33, 36) . As shown in Fig. 7A , SaI/A k /DM and SaI/A k /DM/DO cells treated with BFA are not inhibited for presentation of RNase [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] or HEL 34 -45 , suggesting that presentation of these epitopes may use recycling MHC class II molecules. In contrast, presentation of HEL [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] by SaI/CIITA and SaI/CIITA/DO cells is inhibited by BFA, suggesting that newly synthesized MHC class II molecules are required for presentation of these epitopes. Because presentation of all of these epitopes is inhibited by H2-O (Fig. 6 ), H2-O appears to inhibit presentation of exogenous Ags by both newly synthesized and recycling class II molecules.
H2-O is also present at the cell surface
Previous studies have established that the majority of H2-O is localized to the MIICs by tightly associating with H2-DM (2). However, H2-O may affect Ag presentation by its expression at the cell surface. To determine whether H2-O is expressed on the outer face of the plasma membrane, surface proteins of SaI/A k /DM and SaI/A k /DM/DO cells were biotinylated, and Western blots of H2-O immunoprecipitates were probed with streptavidin-HRP. As shown in Fig. 7C, H2 -O is detected by streptavidin-HRP, and hence is present at the exterior face of the plasma membrane (left panel). To demonstrate that the biotinylation procedure exclusively labels cell surface proteins, c-myc, a cytosolic and nuclear Ag, was immunoprecipitated from biotinylated cells. As shown in Fig. 7C, c-myc is only detected by blotting with c- (38) reported that 10 -15% of total HLA-DM is functional at the cell surface, binding to MHC class II molecules. Therefore, surface class II/H2-DM/ H2-O complexes may exist, which alter the conformation of MHC class II or directly compete for SAg binding sites, and thereby lead to a reduction in SAg binding. 4) Recent studies have shown that in the MIICs, HLA-DO may directly interact with MHC class II and other tetraspan proteins, such as CD82 and CD63, independent of HLA-DM binding (39) . Therefore, H2-O may affect SAg presentation by its interaction with proteins other than H2-DM and via as yet uncharacterized mechanisms.
Regardless of the mechanism by which H2-O reduces SAg-induced T cell activation, the dramatic reduction suggests that H2-O may play a role in vivo in presentation of SAgs. Bacterial SAgs are immunostimulatory proteins that cause significant diseases in humans, ranging from toxic shock syndrome to autoimmune pathologies (28) . These diseases occur when MHC class II ϩ host APC bind and present SAgs to host T cells. Although B cells present SAgs (40) , they are less efficient presenters of SAg than H2-O Ϫ APC, such as dendritic cells (DC) and macrophages (41) . The discrepancy in SAg presentation between B cells, macrophages, and DC was originally attributed to differences in levels of expression of costimulatory and/or MHC class II molecules (41) . However, given the inhibitory effects of H2-O on SAg presentation, it is also possible that DC and macrophages are better SAg presenters because they lack H2-O.
H2-O appears to selectively affect Ag presentation based on the origin of the Ag. That is, presentation of exogenous Ags such as soluble HEL and RNase, is inhibited, whereas presentation of endogenous self Ags, such as self HEL and tumor Ags, is not affected. This dichotomy may reflect differences in where exogenous vs endogenous peptides are loaded onto MHC class II molecules. Recent studies suggest that the binding of endogenous self peptides to MHC class II occurs in the endocytic pathway, as does binding of exogenous peptides (13, 42) . However, binding of endogenous vs exogenous peptides may occur in different compartments of MIICs (13, 18) , and different pHs in these compartments may account for differential effects of H2-O (5, 7).
H2-O expression in mTEC may also play a role in T cell selection in the thymus. mTEC together with bone marrow-derived APC (DC) are major APC for negative selection of developing T lymphocytes in the thymus (10) . mTEC are H2-O ϩ , while DC are H2-O Ϫ (8, 9) . If H2-O functions in mTEC as it does in the SaI transfectants, then mTEC may be inhibited for presentation of exogenous Ags, but not endogenous self Ags. Therefore, mTEC may preferentially delete autoreactive T cells specific for endogenous self Ags, but not T cells reactive to exogenous self Ags. In contrast, because DC are H2-O Ϫ , they may preferentially delete T cells reactive to exogenous self Ags presented by cross-presentation. The combination of H2-O ϩ (mTEC) and H2-O Ϫ (DC) APC may complement each other and delete autoreactive T cells specific for both endogenous and exogenous Ags, and thereby minimize overall autoreactivity. The expression of H2-O in mTEC and its absence in DC may also explain the observation that unlike DC, mTEC do not induce full tolerance (43) .
Note added in proof.
A recent study (44) demonstrated that HLA-DR3 conformation could be altered by HLA-DM in a peptideindependent manner. Therefore, H2-O may reduce SAg presentation in a peptide-independent fashion by either binding directly to class II or by interacting with H2-DM.
